Clinical trial
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00082147 |
|---|---|
| Title | Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer |
| Official title | A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization With the APT-MRI System |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | Biopsy |
| Enrollment | 20 |
| Start date | Apr 29, 2004 |
| Completion | Jun 11, 2018 |
| First posted | Apr 30, 2004 |
| Last update posted | Jun 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: